vimarsana.com
Home
Live Updates
RVS infection: Jabs to protect babies against potentially deadly winter virus pass final trials : vimarsana.com
RVS infection: Jabs to protect babies against potentially deadly winter virus pass final trials
Australian researchers have just completed phase 3 clinical trials of a long-lasting monoclonal antibody treatment called Nirsevimab, which works much like a vaccine.
Related Keywords
Australia ,
Perth ,
Western Australia ,
Sydney ,
New South Wales ,
Australians ,
Australian ,
Nicholas Wood ,
Hannah Moore ,
Mark Butler ,
Fiona Russell ,
Peter Richmond ,
Infectious Diseases At Curtin University ,
Wesfarmers Centre For Vaccines ,
Head Of The Vaccine Trials Group ,
Murdoch Childrens Research Institute ,
Telethon Kids Institute ,
University Of Sydney ,
Vaccine Trials Group ,
Professor Peter Richmond ,
Lancet Infectious Diseases ,
Associate Professor Nicholas Wood ,
Adolescent Health ,
Minister Mark Butler ,
Professor Hannah Moore ,
Wesfarmers Centre ,
Infectious Diseases ,
Curtin University ,
,
vimarsana.com © 2020. All Rights Reserved.